Table 4.

Multivariable Linear Regression Analysis for the CAP Progression Rate.

	Model 1 (Clinical RFs + BACS)				Model 2 (Clinical RFs + CACS + BACS)				Model 3 (Clinical RFs + Segment stenosis score + BACS)
	β	95% CI	t	P	β	95% CI	t	p	β	95% CI	t	p
Age, years	0.002	−0.003–0.007	0.916	0.362	0.002	−0.003–0.007	0.779	0.438	0.002	−0.003–0.007	0.775	0.440
Number of parity	0.004	−0.023–0.030	0.291	0.772	0.003	−0.024–0.030	0.207	0.836	0.004	−0.023–0.030	0.266	0.791
Hypertension, n (%)	−0.026	−0.095–0.043	−0.746	0.457	−0.027	−0.096–0.042	−0.769	0.444	−0.025	−0.094–0.045	−0.704	0.483
Current smoking, n (%)	0.073	−0.128–0.274	0.721	0.472	0.072	−0.130–0.273	0.705	0.483	0.076	−0.126–0.277	0.745	0.458
Systolic blood pressure, mmHg	0.001	0.000–0.003	1.793	0.076	0.001	0.000–0.003	1.818	0.072	0.001	0.000–0.003	1.620	0.108
Serum creatinine, mg/dL	0.122	−0.193–0.437	0.767	0.445	0.134	−0.185–0.452	0.834	0.406	0.104	−0.216–0.423	0.644	0.521
HbA1c, %	0.031	−0.002––0.063	1.840	0.069	0.031	−0.002–0.064	1.851	0.067	0.028	−0.006–0.062	1.651	0.102
High-density lipoprotein, mg/dL	0.000	−0.002–0.002	0.126	0.900	0.000	−0.002–0.002	0.189	0.851	0.000	−0.002–0.002	0.172	0.864
Low-density lipoprotein, mg/dL	0.000	−0.001–0.001	0.378	0.706	0.000	−0.001–0.001	0.319	0.750	0.000	−0.001–0.001	0.332	0.741
Statin therapy after CCTA	−0.023	−0.105–0.059	−0.560	0.577	−0.025	−0.107–0.057	−0.606	0.546	−0.029	−0.113–0.054	−0.693	0.490
CACS					0.000	0.000–0.001	0.645	0.520
SSS									0.010	−0.016–0.035	0.762	0.448
BACS	0.020	0.005–0.035	2.629	0.010	0.019	0.004–0.034	2.556	0.012	0.019	0.004–0.035	2.577	0.011

Abbreviations are the same as those in Tables 1 and 2.